Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: The importance of the nodal down-staging after chemotherapy

European Journal of Cardio-thoracic Surgery

Volumn 20, Issue 6, 2001, Pages 1106-1112

  Voltolini, Luca ^a   Luzzi, Luca ^a   Ghiribelli, Claudia ^a   Paladini, Piero ^a   Di Bisceglie, Maurizio ^a   Gotti, Giuseppe ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Combined modality treatment; Induction chemotherapy; N2 disease; Non small cell lung cancer

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; AGED; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER STAGING; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGOBRONCHIAL FISTULA; FEMALE; HUMAN; LUNG NODULE; LUNG NON SMALL CELL CANCER; MALE; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE;

EID: 0035153272     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(01)00984-8     Document Type: Article

References (21)

1. The role of surgery in N2 lung cancer
2. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung
3. Preoperative chemotherapy for stage lila (N2) lung cancer: the Sloan-Kettering experience with 136 patients
4. Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small-cell lung cancer
5. Induction chemotherapy with mitomycin, vindesin, and cisplatinum for stace III unresectable non-small-cell lung cancer: Results of the Toronto phase II trial
6. Current cisplatinletoposide plus chest radiotherapy followed by surgery for stages IIIA(N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group Phase II Study 8805
7. A randomized trial comparing perioperative chemiotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
8. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
9. Randomized trial of neoadjiuvant therapy for lung cancer: interim analysis
10. Gemcitabine- a new agent in the treatment of non-small cell lung cancer
11. Clinical staging of primary lung cancer
12. Regional lymph node classification for lung cancer staging
13. Revisions in the international system for staging lung cancer
14. Reporting results of cancer treatment
15. Nonparametric estimation from incomplete observations
16. Evaluation of survival data and two new rank order statics arising in its consideration
17. Thoracic radiotherapy does not prolong survival in patients with locally advanced unresectable non-small cell lung cancer
18. The significance of ipsilateral mediastinal lymph mode metastasis (N2 disease) in non-small cell carcinoma of the lung
19. Pretreatment minimal staging for non-small-cell lung cancer: an updated consensus report
20. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases
21. The role of chemotherapy in early-stage (stage I and II) resectable non-small cell lung cancer